IL10 and gastroenteritis: The central role of increased IL-10 production by SCFA-treated Th1 cells in suppression of Th1-driven intestinal inflammation is further confirmed by the fact that blockade of IL-10 pathway exacerbated colitis induced by butyrate-treated Th1 cells (Fig. 4).